Medicines Co. (MDCO) Posts Narrower-than-Expected Q3 Loss

October 26, 2016 7:02 AM EDT
Get Alerts MDCO Hot Sheet
Trade MDCO Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($0.64), $0.66 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $37.6 million versus the consensus estimate of $37.26 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment